NOTO, ALESSANDRO
Distribuzione geografica
Continente | # |
---|---|
NA - Nord America | 61 |
EU - Europa | 12 |
AS - Asia | 9 |
SA - Sud America | 2 |
AF - Africa | 1 |
Totale | 85 |
Nazione | # |
---|---|
US - Stati Uniti d'America | 59 |
CN - Cina | 6 |
IT - Italia | 4 |
FR - Francia | 3 |
GB - Regno Unito | 3 |
CO - Colombia | 2 |
TH - Thailandia | 2 |
CA - Canada | 1 |
DE - Germania | 1 |
ES - Italia | 1 |
PR - Porto Rico | 1 |
TW - Taiwan | 1 |
ZA - Sudafrica | 1 |
Totale | 85 |
Città | # |
---|---|
Cambridge | 6 |
Ashburn | 5 |
Fairfield | 5 |
Houston | 5 |
Seattle | 5 |
Beijing | 4 |
Ann Arbor | 3 |
Bangkok | 2 |
Buffalo | 2 |
Medellín | 2 |
Santa Cruz | 2 |
Boardman | 1 |
Bronx | 1 |
Chicago | 1 |
Clearwater | 1 |
Denver | 1 |
Hamilton | 1 |
Las Vegas | 1 |
London | 1 |
Milpitas | 1 |
Monza | 1 |
Munich | 1 |
Peschiera | 1 |
Pittsburgh | 1 |
Pontedera | 1 |
Provo | 1 |
San Diego | 1 |
San Juan | 1 |
Sevilla | 1 |
Silverton | 1 |
Southend | 1 |
Taipei | 1 |
Woodbridge | 1 |
Yuba City | 1 |
Totale | 64 |
Nome | # |
---|---|
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy), file dfa8b9a2-c97f-748b-e053-3a05fe0a3a96 | 80 |
Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE Study, file 1db5974e-05ab-4d9c-b981-be4419679908 | 7 |
Use of GELSECTAN® in patients with irritable bowel syndrome (IBS): An Italian experience, file dfa8b9aa-273b-748b-e053-3a05fe0a3a96 | 1 |
Totale | 88 |
Categoria | # |
---|---|
all - tutte | 290 |
article - articoli | 0 |
book - libri | 0 |
conference - conferenze | 0 |
curatela - curatele | 0 |
other - altro | 0 |
patent - brevetti | 0 |
selected - selezionate | 0 |
volume - volumi | 0 |
Totale | 290 |
Totale | Lug | Ago | Sett | Ott | Nov | Dic | Gen | Feb | Mar | Apr | Mag | Giu | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2020/2021 | 38 | 5 | 2 | 5 | 0 | 3 | 6 | 2 | 4 | 2 | 4 | 1 | 4 |
2021/2022 | 23 | 1 | 3 | 3 | 1 | 2 | 0 | 2 | 3 | 1 | 1 | 4 | 2 |
2022/2023 | 15 | 1 | 0 | 6 | 4 | 0 | 1 | 1 | 0 | 0 | 0 | 2 | 0 |
2023/2024 | 12 | 1 | 0 | 1 | 0 | 1 | 4 | 1 | 2 | 2 | 0 | 0 | 0 |
Totale | 88 |